Показано 0 из 0
Дата |
---|
28.06.2024 |
27.06.2024 |
26.06.2024 |
25.06.2024 |
24.06.2024 |
21.06.2024 |
20.06.2024 |
19.06.2024 |
17.06.2024 |
14.06.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
|
0.008
|
0.009
|
0.008
|
|
|
8 413.80
|
|
|
|
|
0.008
|
0.01
|
0.009
|
|
|
7 315.48
|
|
|
|
|
0.007
|
0.008
|
0.007
|
|
|
1 724.68
|
|
|
|
|
0.008
|
0.008
|
0.008
|
|
|
1 251.77
|
|
|
|
|
0.007
|
0.007
|
0.007
|
|
|
91.00
|
|
|
|
|
0.008
|
0.008
|
0.008
|
|
|
1 920.00
|
|
|
|
|
0.007
|
0.007
|
0.007
|
|
|
32 319.41
|
|
|
|
|
0.006
|
0.006
|
0.006
|
|
|
366.41
|
|
|
|
|
0.006
|
0.006
|
0.006
|
|
|
12 742.37
|
|
|
|
|
0.006
|
0.006
|
0.006
|
|
|
11 316.57
|
|
Anagenics Limited (бывш. Cellmid Limited) researches and develops therapeutic, prognostic, and diagnostic products using midkine. Midkine is a heparin binding growth factor used by the company in products involving inflammatory and autoimmune conditions and cancer.